期刊文献+

血液透析联合血液灌流、骨化三醇、维C透析液治疗血透患者骨质疏松的临床观察 被引量:1

The research about hemodialysis unite hemoperfusion, calcitriol, dislysate of VitC upon Osteoporosis
原文传递
导出
摘要 目的 探讨血液透析联合血液灌流、骨化三醇、维生素C透析液对维持性血液透析(MHD)患者骨质疏松的疗效.方法 将60例MHD患者按有/无骨质疏松分治疗组(A,30例,血液透析联合血液灌流、骨化三醇、维C透析液)与对照组(B,30例,单纯血液透析).比较两组治疗6个月后患者疗效、副作用及骨密度(BMD)值、胰岛素样生长因子-1(IGF-1)、肿瘤坏死因子-a(TNF-a)、甲状旁腺素(PTH)、血肌酐(Scr)、血钙、血磷等指标变化.结果 A组疗效优于B组(P<0.05),两组副作用差异无统计学意义(P>0.05);治疗后A组BMD值、IGF-1水平高于B组,而TNF-a、血磷、PTH水平低于B组(P<0.05);两组治疗前后Scr、Ca水平差异无统计学意义(P>0.05).治疗前A组IGF-1与骨密度(BMD)值呈正相关,TNF-a、PTH、P与BMD值呈负相关,B组各指标与BMD值无线性回归关系,治疗后A组各指标与BMD值无线性回归关系.结论 血液透析联合血液灌流、骨化三醇、维C透析液治疗能显著降低血PTH、血磷、TNF-a水平,对MHD患者骨质疏松的治疗安全有效. Objectives To explore curative effect of osteoporosis of hemodialysis unite hemoperfusion,calcitriol,dislysate of VitC in patient with maintenance hemodialysis.Methods Sixty patient who had been undergoing maintenance hemodialysis were divided into treatment group (A,30,patients who took hemodialysis unite Hemoperfusion,calcitriol,dislysate of VitC) and control group (B,40,patients who took hemodialysis alone) according to whether they had/didnt have osteoporosis.Observed curative effect,side effect and vibration of BMD,IGF-1,TNF-a,PTH,SScr,blood calcium,phosphorus,etc after treatment 6 months.Results The curative effect of group A was better than that of group B (P < 0.05),there was no significant difference of side effects between two groups(P >0.05) ; the levels of BMD、IGF-1 of group A were higher than those of group B after treatment ;the levels of BMD、IGF-1 of group A were higher than those of group B after treatment,and the levels of TNF-a、P、PTH of group A were lower than those of group B(P < 0.05 all),there were no significant differences of Scr,Ca levels after treatments between two groups(P >0.05 all).before treatment,group A had positive correlation of BMD value,and group B had no linear regression correlation of BMD value,The levels of TNF-a、PTH 、P had negative correlation of BMD value,and IGF-1 had greatest influences on BMD value.after treatment,Indices of group A had no linear regression correlation of BMD value.Conclusions Hemodialysis unite hemoperfusion,calcitriol,dislysate of VitC could reduce the levels of PTH、p、TNF-a,it had safe and valid effect on osteoporosis in patients with maintenance hem dialysis.
出处 《国际泌尿系统杂志》 2014年第1期49-52,共4页 International Journal of Urology and Nephrology
关键词 肾透析 灌流 骨化三醇 骨质疏松 Renal Dialysis Perfusion Calcutriol Osteoporosis
  • 相关文献

参考文献9

  • 1中国人骨质疏松症建议诊断标准(第二稿)[J].中国骨质疏松杂志,2000,6(1):1-3. 被引量:1234
  • 2Henandez JD, Weaseling K, Salusky IB. Role of parathyroid hor- monr and Therapy with active vitamin D sterols in renal osteodys- trophy, SeminDial [ J ] ,2005,18 : 290 - 295.
  • 3LIM S, GUN NT. Secondary hyperparathyroidism and calcium phosphate control in a hemodialysis population [ J ]. Acta med Indones, 2009, 39(2):71 -74.
  • 4Ajayk Nangia, Oya Hil. Testicular Matruation ArresttoTestis Canc- er: Spectrum of Expression of the Vitamin D Receptor and Vitam in D Treatment In Vitro [ J ]. Urology,2007,178 : 1091 - 1096.
  • 5Richter A, Kuhlmann MK, Seibert E, et al. Vitamin C deficiency and secondary Hyperparathyroidism in chronic haemodialysis pa- tients [ J] Nephro Dial Transplant, 2008,23:2058 - 2063.
  • 6Bohm V,Tiroke k,Schneider S,et al. Vitamin C status of patients with chronic renal failure, dialysis patients and patient after renal transplantation [ J ]. Int J Vitam Nutr Res, 1997,67 : 262 - 266.
  • 7谢红昌,赵显国,王欣芳.维生素C透析液对继发性甲状旁腺功能亢进的影响[J].中国血液净化,2010,9(5):258-260. 被引量:1
  • 8Talaulikar VS, Chambers T, Manyonda I. Exploiting the antioxi-dant potential of a common vitamin : Could vitamin C prevent post- menopausal osteoporosis[ J] ? J Obstet Gynaecol Res. 2011,10. (10). 1447 - 1456.
  • 9Kalbe C, Man M, Rehfeldt C. Developmental changes and the im- pact of flavones on mRNA expression of IGF - I receptor, EGF re- ceptor and related growth factors in porcine skeletal musele eell cultures. Growth Horm IGF Res[J]. 2008,18(5) :424-433.

二级参考文献17

  • 1余永华.维生素C的不良反应[J].安徽医药,2000,4(3):48-48. 被引量:1
  • 2陈向前,陈维广.阿法迪三治疗规律血液透析患者继发性甲状旁腺功能亢进的临床研究[J].中国血液净化,2005,4(6):334-335. 被引量:5
  • 3Salem MM.Hyperparathyroidism in the hemodialysis population:A survey of 612 patients[J].Am J Kidney Dis,1997,29:862-865.
  • 4Richter A,Kuhlmann MK,Seibert E,et al.Vitamin C deficiency and secondary hyperparathyroidism in chronic haemudialysis patients[J].Nephrol Dial Transplant,2008,23:2058-2063.
  • 5Friedman PA,Coutermarsh BA,Kennedy SW,et al.Parathy-roid hormone stimulation of calcium transport is mediated by dual signaling mechanisms involving protein kinase A and protein kinase C[J].Endocrinology,1996,137:13-20.
  • 6Pearce SH,Thakker RV.The calcium-sensing receptor:Insights into extracellular calcium homuostasis in health and disease[J].J Endocrinol,1997,154:371-378.
  • 7Abou-Samra AB,Juppner H,Force T,et al.Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells:A single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium[J].Proc Natl Read Sci USA,1992,89:2732-2736.
  • 8Lopez-Lluch G,Fernandez-Ayala DJ,Alcain FJ,et al.Inhibition of COX activity by NSAIDs or ascorbate in-creases cAMP levels and enhances differentiation in lalpha,25-dihydroxyvitamin D3-induced HL-60 cells[J].Arch Biochem Biophys,2005,436:32-39.
  • 9McCauley LK,Koh AJ,Beecher CA,et al.PTH/PTHrP receptor is temporally regulated during osteoblast differentia-tion and is associated with collagen synthesis[J].J Cell Biochem,1996,61:638-647.
  • 10Yang Z,Copolov DL,Lim AT.Ascorbic acid augments the adenylyl cyclase-cAMP system mediated POWC mRNA expres-sion and beta-endorDhin secretion from hypothalamic neu-rons in culture[J].Brain Res,1996,706:243-248.

共引文献1233

同被引文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部